NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback